Cargando…

Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer’s Disease

The etiology for late-onset Alzheimer’s disease (LOAD), which accounts for >95% of Alzheimer’s disease (AD) cases, is unknown. Emerging evidence suggests that cellular senescence contributes importantly to AD pathophysiology, although the mechanisms underlying brain cell senescence and by which s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Chun-Sun, Rana, Tapasi, Jin, Lee-Way, Farr, Susan A, Morley, John E, Qin, Hongwei, Liu, Gang, Liu, Rui-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017160/ https://www.ncbi.nlm.nih.gov/pubmed/37008063 http://dx.doi.org/10.14336/AD.2022.1220

Ejemplares similares

PAI-1 Regulation of p53 Expression and Senescence in Type II Alveolar Epithelial Cells
por: Rana, Tapasi, et al.
Publicado: (2023)

Aging, Cellular Senescence, and Alzheimer’s Disease
por: Liu, Rui-Ming
Publicado: (2022)

Activators and inhibitors of the plasminogen system in Alzheimer’s disease
por: Barker, Rachel, et al.
Publicado: (2012)

SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence
por: Wan, Yan-Zhen, et al.
Publicado: (2014)

Skeletal Senescence with Aging and Type 2 Diabetes
por: Farr, Joshua Nicholas
Publicado: (2023)

Neuronal Senescence in the Aged Brain
por: Chou, Shu-Min, et al.
Publicado: (2023)

Divergent Regulation of Alveolar Type 2 Cell and Fibroblast Apoptosis by Plasminogen Activator Inhibitor 1 in Lung Fibrosis
por: Jiang, Chunsun, et al.
Publicado: (2021)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

The plasminogen activating system in the pathogenesis of Alzheimer’s disease
por: Yepes, Manuel
Publicado: (2021)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Cellular Senescence in Brain Aging
por: Sikora, Ewa, et al.
Publicado: (2021)

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease
por: Hansen, Henrik H., et al.
Publicado: (2015)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden
por: Tomadesso, Clémence, et al.
Publicado: (2022)

Senescent Microglia: The Key to the Ageing Brain?
por: Greenwood, Eleanor K., et al.
Publicado: (2021)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer’s disease
por: Tang, Mei-Yun, et al.
Publicado: (2022)

The role of plasminogen activator inhibitor-1 in gastric mucosal protection
por: Kenny, Susan, et al.
Publicado: (2013)

Functional Stability of Plasminogen Activator Inhibitor-1
por: Yasar Yildiz, Songul, et al.
Publicado: (2014)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Infection susceptibility and immune senescence with advancing age replicated in accelerated aging Lmna (Dhe) mice
por: Xin, Lijun, et al.
Publicado: (2015)

Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer’s disease
por: Cui, Bo, et al.
Publicado: (2018)

DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer’s Disease
por: Wong, Genper Chi-Ngai, et al.
Publicado: (2023)

Plasminogen activator inhibitor‐1 augments damage by impairing fibrinolysis after traumatic brain injury
por: Griemert, Eva‐Verena, et al.
Publicado: (2019)

Levels of microRNA-181b and plasminogen activator inhibitor-1 are associated with hypertensive disorders complicating pregnancy
por: CHEN, YAN-SHAN, et al.
Publicado: (2014)

Cellular senescence in aging and osteoarthritis: Implications for cartilage repair
por: Toh, Wei Seong, et al.
Publicado: (2016)

Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
Publicado: (1988)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
por: Demers-Mathieu, Veronique, et al.
Publicado: (2022)

Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
por: Jasmiad, Nurbadriah binti, et al.
Publicado: (2022)

Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
por: Yasuma, Taro, et al.
Publicado: (2022)

Astrocyte Senescence and Alzheimer’s Disease: A Review
por: Han, Xiaojuan, et al.
Publicado: (2020)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_l7cpb1626at8lu1k0b558jonai